Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: Systematic review and meta-analysis

BMJ (Online)

Volumn 352, Issue , 2016, Pages

  Bryce, Ashley ^a   Hay, Alastair D ^a   Lane, Isabel F ^a   Thornton, Hannah V ^a   Wootton, Mandy ^b   Costelloe, Céire ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; NITROFURANTOIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIUM ISOLATE; CHILD; CHILD CARE; DRUG EXPOSURE; ESCHERICHIA COLI; EXPERIMENTAL STUDY; HUMAN; INFECTION RISK; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; URINARY TRACT INFECTION; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; MICROBIOLOGY; PATHOGENICITY; PRESCHOOL CHILD; PRIMARY HEALTH CARE; URINARY TRACT INFECTIONS;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PREVALENCE; PRIMARY HEALTH CARE; URINARY TRACT INFECTIONS;

EID: 84962548264     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i939     Document Type: Review

References (97)

1. Majeed A, Moser K. Age-and sex-specific antibiotic prescribing patterns in general practice in England and Wales in 1996. Br J Gen Pract 1999;49:735-6.
2. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987;9:1065-78. doi:10.1093/ clinids/9.6.1065.
3. Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam Med 2007;20:533-9. doi:10.3122/jabfm.2007.06.070019.
4. Ready D, Lancaster H, Qureshi F, Bedi R, Mullany P, Wilson M. Effect of amoxicillin use on oral microbiota in young children. Antimicrob Agents Chemother 2004;48:2883-7. doi:10.1128/AAC.48.8.2883-2887.2004.
5. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096. doi:10.1136/bmj.c2096.
6. Car J. Urinary tract infections in women: diagnosis and management in primary care. BMJ 2006;332:94-7. doi:10.1136/bmj.332.7533.94.
7. Price E, Pallett A, Gilbert RD, Williams C. Microbiological aspects of the UK National Institute for Health and Clinical Excellence (NICE) guidance on urinary tract infection in children. J Antimicrob Chemother 2010;65:836-41. doi:10.1093/jac/dkq045.
8. Gaspari RJ, Dickson E, Karlowsky J, Doern G. Antibiotic resistance trends in paediatric uropathogens. Int J Antimicrob Agents 2005;26:267-71. doi:10.1016/j.ijantimicag.2005.07.009.
9. World Health Organization. Antimicrobial resistance: global report on surveillance. WHO, 2014. http://www.who.int/drugresistance/ documents/surveillancereport/en/.
10. Special Eurobarometer 338. Antimicrobial resistance. Eurobarometer 338, 2009. http://ec.europa.eu/health/antimicrobial-resistance/ docs/ebs-338-en.pdf.
11. Guneysel O, Onur O, Erdede M, Denizbasi A. Trimethoprim/ sulfamethoxazole resistance in urinary tract infections. J Emerg Med 2009;36:338-41. doi:10.1016/j.jemermed.2007.08.068.
12. Cizman M, Beovic B, Krcmery V, et al. Antibiotic policies in Central Eastern Europe. Int J Antimicrob Agents 2004;24:199-204. doi:10.1016/j.ijantimicag.2004.03.016.
13. Levy SB. The challenge of antibiotic resistance. Sci Am 1998;278:46-53. doi:10.1038/scientificamerican0398-46.
14. Chen CJ, Huang YC. New epidemiology of Staphylococcus aureus infection in Asia. Clin Microbiol Infect 2014;20:605-23. doi:10.1111/1469-0691.12705.
15. Organisation for Economic Co-operation and Development (OECD). OECD, 2014. http://www.oecd.org/.
16. Holten KB, Onusko EM. Appropriate prescribing of oral beta-lactam antibiotics. Am Fam Physician 2000;62:611-20.
17. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Secondary Cochrane Handbook for Systematic Reviews of Interventions 2011. www.cochrane-handbook.org.
18. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9, W64. doi:10.7326/0003-4819-151-4-200908180-00135.
19. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health 2013;67:974-8. doi:10.1136/jech-2013-203104.
20. Edlin RS, Shapiro DJ, Hersh AL, Copp HL. Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol 2013;190:222-7. doi:10.1016/j.juro.2013.01.069.
21. Falagas ME, Polemis M, Alexiou VG, Marini-Mastrogiannaki A, Kremastinou J, Vatopoulos AC. Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece. Med Sci Monit 2008;14:CR75-9.
22. Conway PH, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007;298:179-86. doi:10.1001/jama.298.2.179.
23. Fritzsche M, Ammann RA, Droz S, Bianchetti MG, Aebi C. Changes in antimicrobial resistance of Escherichia coli causing urinary tract infections in hospitalized children. Eur J Clin Microbiol Infect Dis 2005;24:233-5. doi:10.1007/s10096-005-1301-2.
24. Duffy MA, Hernandez-Santiago V, Orange G, Davey PG, Guthrie B. Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis. Br J Gen Pract 2013;63:238-43. doi:10.3399/bjgp13X665198.
25. Yolbaş I, Tekin R, Kelekci S, et al. Community-acquired urinary tract infections in children: pathogens, antibiotic susceptibility and seasonal changes. Eur Rev Med Pharmacol Sci 2013;17:971-6.
26. Cullen IM, Manecksha RP, McCullagh E, et al. An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009. Ir J Med Sci 2013;182:81-9. doi:10.1007/ s11845-012-0834-5.
27. Guner SN, Gokturk B, Bayrakci US, et al. The distribution of communityacquired gram negative microorganisms isolated from the urine samples of children, and the evaluation of increase in antibiotic resistance between the years 2003-2010. Turk Pediatri Arsivi 2012;47:107-13.
28. Mantadakis E, Tsalkidis A, Panopoulou M, et al. Antimicrobial susceptibility of pediatric uropathogens in Thrace, Greece. Int Urol Nephrol 2011;43:549-55. doi:10.1007/s11255-010-9768-x.
29. Caracciolo A, Bettinelli A, Bonato C, et al. Antimicrobial resistance among Escherichia coli that cause childhood community-acquired urinary tract infections in Northern Italy. Ital J Pediatr 2011;37:3. doi:10.1186/1824-7288-37-3.
30. Paschke AA, Zaoutis T, Conway PH, Xie D, Keren R. Previous antimicrobial exposure is associated with drug-resistant urinary tract infections in children. Pediatrics 2010;125:664-72. doi:10.1542/peds.2009-1527.
31. Senel S, Karacan C, Erkek N, Gol N. A single-center experience of antimicrobial resistance patterns in pediatric urinary tract infection. Med Princ Pract 2010;19:359-63. doi:10.1159/000316373.
32. Catal F, Bavbek N, Bayrak O, et al. Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006. Int Urol Nephrol 2009;41:953-7. doi:10.1007/s11255-008-9445-5.
33. Prelog M, Schiefecker D, Fille M, Wurzner R, Brunner A, Zimmerhackl LB. Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy. Pediatr Nephrol 2008;23:597-602. doi:10.1007/s00467-007-0701-1.
34. Gaspari RJ, Dickson E, Karlowsky J, Doern G. Multidrug resistance in pediatric urinary tract infections. Microb Drug Resist 2006;12:126-9. doi:10.1089/mdr.2006.12.126.
35. Mehr SS, Powell CV, Curtis N. Cephalosporin resistant urinary tract infections in young children. J Paediatr Child Health 2004;40:48-52. doi:10.1111/j.1440-1754.2004.00290.x.
36. Burman WJ, Breese PE, Murray BE, et al. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am J Med 2003;115:358-64. doi:10.1016/S0002-9343(03)00372-3.
37. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003;88:444-5. doi:10.1136/ adc.88.5.444.
38. McLoughlin TG Jr, , Joseph MM. Antibiotic resistance patterns of uropathogens in pediatric emergency department patients. Acad Emerg Med 2003;10:347-51. doi:10.1111/j.1553-2712.2003. tb01347.x.
39. Ashkenazi S, Even-Tov S, Samra Z, Dinari G. Uropathogens of various childhood populations and their antibiotic susceptibility. Pediatr Infect Dis J 1991;10:742-6. doi:10.1097/00006454-199110000-00005.
40. Grüneberg RN, Shaw EJ. The influence of antibiotic treatment on resistance patterns of coliform bacilli in childhood urinary-tract infection. J Med Microbiol 1976;9:233-7. doi:10.1099/00222615-9-2-233.
41. Bryce A, Gibb AP, Willocks L, et al. Patterns of antibiotic resistance in community-acquired urinary tract infections within Lothian caused by Escherichia coli between 2005 and 2009. J Infect 2011;63:e61-2doi:10.1016/j.jinf.2011.04.112.
42. McGregor JC, Quach Y, Bearden DT, Smith DH, Sharp SE, Guzman-Cottrill JA. Variation in antibiotic susceptibility of uropathogens by age among ambulatory pediatric patients. J Pediatr Nurs 2014;29:152-7. doi:10.1016/j.pedn.2013.09.001.
43. Swerkersson S, Jodal U, Ahrén C, Hansson S. Urinary tract infection in small outpatient children: the influence of age and gender on resistance to oral antimicrobials. Eur J Pediatr 2014;173:1075-81. doi:10.1007/s00431-014-2289-3.
44. Anatoliotaki M, Galanakis E, Schinaki A, Stefanaki S, Mavrokosta M, Tsilimigaki A. Antimicrobial resistance of urinary tract pathogens in children in Crete, Greece. Scand J Infect Dis 2007;39:671-5. doi:10.1080/00365540701199899.
45. Gallegos J, Márquez S, Morales K, Peña A. [Etiologic and antibiotic susceptibility profile of the first episode of febrile urinary tract infection]. Rev Chilena Infectol 2013;30:474-9. doi:10.4067/ S0716-10182013000500002.
46. Ismaili K, Wissing KM, Lolin K, et al. Characteristics of first urinary tract infection with fever in children: a prospective clinical and imaging study. Pediatr Infect Dis J 2011;30:371-4. doi:10.1097/INF.0b013e318204dcf3.
47. Ipek IO, Bozaykut A, Arman DC, Sezer RG. Antimicrobial resistance patterns of uropathogens among children in Istanbul, Turkey. Southeast Asian J Trop Med Public Health 2011;42:355-62.
48. Yildirim M, Sahin I, Gulcan A, et al. Antimicrobial susceptibility and uropathogens isolated from children and adults with communityacquired urinary tract infections. Turkiye Klinikleri J Med Sci 2010;30:533-8doi:10.5336/medsci.2008-9024.
49. Borsari AG, Bucher B, Brazzola P, Simonetti GD, Dolina M, Bianchetti MG. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland. Clin Ther 2008;30:2090-5. doi:10.1016/j.clinthera.2008.11.002.
50. Allen UD, MacDonald N, Fuite L, Chan F, Stephens D. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 1999;160:1436-40.
51. Topaloglu R, Er I, Dogan BG, et al. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol 2010;25:919-25. doi:10.1007/s00467-009-1431-3.
52. Alshara MA. Uropathogens and their susceptibility patterns in children at Princess Rhmah Hospital, Jordan. Jordan Med J 2011;45:44-50.
53. Al-Saif MA, Al-Abdi SY, Samara JT, et al. Antibiotic sensitivity pattern of common community-acquired uropathogens in children in a Saudi tertiary care hospital. Saudi Med J 2012;33:565-7.
54. Valavi E, Nikfar R, Ahmadzadeh A, et al. The last three years antibiotic susceptibility patterns of uropathogens in southwest of Iran.Jundishapur J Micro, 2013:6.
55. Muoneke V, Ibekwe M, Ibekwe R. Childhood urinary tract infection in abakaliki: etiological organisms and antibiotic sensitivity pattern. Ann Med Health Sci Res 2012;2:29-32. doi:10.4103/2141-9248.96933.
56. Farshad S, Anvarinejad M, Tavana AM, et al. Molecular epidemiology of Escherichia coli strains isolated from children with community acquired urinary tract infections. Afr J Microbiol Res 2011;5:4476-83.
57. Al-Mardeni RI, Batarseh A, Omaish L, Shraideh M, Batarseh B, Unis N. Empirical treatment for pediatric urinary tract infection and resistance patterns of uropathogens, in Queen Alia hospital and prince A'Isha military center - Jordan. Saudi J Kidney Dis Transpl 2009;20:135-9.
58. Guidoni EB, Berezin EN, Nigro S, Santiago NA, Benini V, Toporovski J. Antibiotic resistance patterns of pediatric community-acquired urinary infections. Braz J Infect Dis 2008;12:321-3. doi:10.1590/ S1413-86702008000400013.
59. Rai GK, Upreti HC, Rai SK, Shah KP, Shrestha RM. Causative agents of urinary tract infections in children and their antibiotic sensitivity pattern: a hospital based study. Nepal Med Coll J 2008;10:86-90.
60. Goldraich NP, Manfroi A. Febrile urinary tract infection: Escherichia coli susceptibility to oral antimicrobials. Pediatr Nephrol 2002;17:173-6. doi:10.1007/s00467-001-0808-8.
61. Sharef SW, El-Naggari M, Al-Nabhani D, Al Sawai A, Al Muharrmi Z, Elnour I. Incidence of antibiotics resistance among uropathogens in Omani children presenting with a single episode of urinary tract infection. J Infect Public Health 2015;8:458-65. doi:10.1016/j.jiph.2015.01.005.
62. Sharan R, Kumar D, Mukherjee B. Bacteriology and antibiotic resistance pattern in community acquired urinary tract infection. Indian Pediatr 2013;50:707. doi:10.1007/s13312-013-0195-9.
63. Mandal J, Acharya NS, Buddhapriya D, Parija SC. Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli. Indian J Med Res 2012;136:842-9.
64. Sharma A, Shrestha S, Upadhyay S, Rijal P. Clinical and bacteriological profile of urinary tract infection in children at Nepal Medical College Teaching Hospital. Nepal Med Coll J 2011;13:24-6.
65. Wu J-H, Chiou Y-H, Chang J-T, Wang HP, Chen YY, Hsieh KS. Urinary tract infection in infants: a single-center clinical analysis in southern Taiwan. Pediatr Neonatol 2012;53:283-8. doi:10.1016/j.pedneo.2012.08.003.
66. Farshad S, Ranjbar R, Japoni A, Hosseini M, Anvarinejad M, Mohammadzadegan R. Microbial susceptibility, virulence factors, and plasmid profiles of uropathogenic Escherichia coli strains isolated from children in Jahrom, Iran. Arch Iran Med 2012;15:312-6.
67. Pourakbari B, Ferdosian F, Mahmoudi S, et al. Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young patients from Iran. Braz J Microbiol 2012;43:766-9. doi:10.1590/S1517-83822012000200041.
68. Farshad S, Emamghoraishi F, Japoni A. Association of virulent genes hly, sfa, cnf-1 and pap with antibiotic sensitivity in Escherichia coli strains isolated from children with community-acquired UTI. Iran Red Crescent Med J 2010;12:33-7.
69. Adjei O, Opoku C. Urinary tract infections in African infants. Int J Antimicrob Agents 2004;24(Suppl 1):S32-4. doi:10.1016/j.ijantimicag.2004.02.007.
70. Al-Mugeiren MM, Qadri SM. Bacteriologic profile and drug resistance in pediatric patients with symptomatic bacteriuria. Clin Ther 1996;18:295-300. doi:10.1016/S0149-2918(96)80010-5.
71. Helin I, Araj GF. Antibiogram of urinary tract isolates in Kuwait. Scand J Infect Dis 1986;18:447-50. doi:10.3109/00365548609032362.
72. Narchi H, Al-Hamdani M. First and recurrent pediatric urinary tract infections: do they have different antibiotic susceptibilities?J Chemother 2008;20:472-7. doi:10.1179/joc.2008.20.4.472.
73. Brown BJ, Asinobi AO, Fatunde OJ, Osinusi K, Fasina NA. Antimicrobial sensitivity pattern of organisms causing urinary tract infection in children with sickle cell anaemia in Ibadan, Nigeria. West Afr J Med 2003;22:110-3.
74. Fredrick F, Francis JM, Fataki M, et al. Aetiology, antimicrobial susceptibility and predictors of urinary tract infection among febrile under-fives at Muhimbili National Hospital, Dar es Salaam-Tanzania. Afr J Microbiol Res 2013;7:1029-34.
75. Afsharpaiman S, Bairaghdar F, Torkaman M, et al. Bacterial Pathogens and Resistance Patterns in Children With Community-Acquired Urinary Tract Infection: A Cross Sectional Study. J Comprehensive Pediatrics 2012;3:16-20doi:10.17795/compreped-7078.
76. Sedighi I, Solgi A, Amanati A, Alikhani MY. Choosing the correct empirical antibiotic for urinary tract infection in pediatric: Surveillance of antimicrobial susceptibility pattern of Escherichia coli by E-Test method. Iran J Microbiol 2014;6:387-91.
77. Susceptibility. British Society for Antimicrobial Chemotherapy, 2014. http://bsac.org.uk/susceptibility/.
78. CLSI. Clinical Laboratory Standards Institute, 2014. http://clsi.org/ about-clsi/.
79. Guidoni EB, Berezin EN, Nigro S, Santiago NA, Benini V, Toporovski J. Antibiotic resistance patterns of pediatric community-acquired urinary infections. Braz J Infect Dis 2008;12:321-3. doi:10.1590/ S1413-86702008000400013.
80. World Health Organization. Antimicrobial resistance-draft global action plan on antimicrobial resistance. WHO, 2015. http:// apps.who. int/gb/ebwha/pdf-files/WHA68/A68-20-en.pdf?ua=1.
81. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 2011;11:692-701. doi:10.1016/S1473-3099(11)70054-8.
82. Donkor ES, Tetteh-Quarcoo PB, Nartey P, Agyeman IO. Self-medication practices with antibiotics among tertiary level students in Accra, Ghana: a cross-sectional study. Int J Environ Res Public Health 2012;9:3519-29. doi:10.3390/ijerph9103519.
83. Wachter DA, Joshi MP, Rimal B. Antibiotic dispensing by drug retailers in Kathmandu, Nepal. Trop Med Int Health 1999;4:782-8. doi:10.1046/j.1365-3156.1999.00476.x.
84. Akinyandenu O, Akinyandenu A. Irrational use and non-prescription sale of antibiotics in Nigeria, a need for change. J Sci Innov Res 2014;3:251-7.
85. Bin Abdulhak AA, Altannir MA, Almansor MA, et al. Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: a cross sectional study. BMC Public Health 2011;11:538. doi:10.1186/1471-2458-11-538.
86. European Centre for Disease Prevention and Control. Antimicrobial resistance interactive database: EARS-Net. ECDC, 2014. http://ecdc. europa.eu/en/activities/surveillance/EARS-Net/Pages/index.aspx
87. Centre for Disease Dynamics Economics and Policy (CDDEP). Resistance map. CDDEP, 2010. http://www.cddep.org/projects/ resistance-map.
88. Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008;7:13. doi:10.1186/1476-0711-7-13.
89. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003;46:94-100. doi:10.1053/jinf.2002.1091.
90. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002;46:2540-5. doi:10.1128/ AAC.46.8.2540-2545.2002.
91. Sanchez GV, Baird AM, Karlowsky JA, Master RN, Bordon JM. Nitrofurantoin retains antimicrobial activity against multidrugresistant urinary Escherichia coli from US outpatients. J Antimicrob Chemother 2014;69:3259-62. doi:10.1093/jac/dku282.
92. Uwaezuoke JC, Ogbulie JN. Antibiotic sensitivity pattern of urinary tract pathogens in Port-Harcourt, Nigeria. J Appl Sci Environ Managment 2006;10:103-7.
93. Turnidge J, Christiansen K. Antibiotic use and resistance - proving the obvious. Lancet 2005;365:548-9. doi:10.1016/S0140-6736(05)70770-4.
94. Sommet A, Sermet C, Boëlle PY, Tafflet M, Bernède C, Guillemot D. No significant decrease in antibiotic use from 1992 to 2000, in the French community. J Antimicrob Chemother 2004;54:524-8. doi:10.1093/jac/dkh342.
95. Gupta K, Hooton TM, Naber KG, et al. Infectious Diseases Society of America European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103-20. doi:10.1093/cid/ciq257.
96. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009;64(Suppl 1):i3-10. doi:10.1093/jac/dkp256.
97. Zhanel GG, Hisanaga TL, Laing NM, et al. NAUTICA Group. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2005;26:380-8. doi:10.1016/j. ijantimicag.2005.08.003.